genomic profiling of pscc reveals major biomarkers for the efficacy of immunotherapy
Published 1 year ago • 91 plays • Length 2:33Download video MP4
Download video MP3
Similar videos
-
32:54
role of genomics in identifying biomarkers for response and resistance to anti-cancer immunotherapy
-
10:03
an overview of comprehensive genomic profiling
-
21:16
the utility and potential of comprehensive genomic profiling
-
26:46
developing next generation biomarkers: a new approach
-
0:35
immune checkpoint inhibitors: recent progress and potential biomarkers - 5ii genetic signatures
-
5:23
mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy
-
24:44
genetic technologies for the discovery and verification of cancer immunotherapy biomarkers
-
1:49
immunotherapy and beyond for lung cancer prevention
-
0:51
immune checkpoint inhibitors: recent progress and potential biomarkers - 5iii genetic signatures
-
18:24
imaging biomarkers to predict the efficacy of cancer immunotherapy
-
5:16
predictive biomarkers for immunotherapy in upper gi cancers
-
24:18
immunotherapy biomarkers and patient selection
-
1:11:32
refining best practices in cancer immunotherapy biomarker testing and pathologic response assessment
-
0:45
immune checkpoint inhibitors: recent progress and potential biomarkers - 5i genetic signatures
-
14:06
dr. nandini menon: biomarkers for predicting immunotherapy efficacy (non-pd-l1/msi/tmb) | crsf
-
39:55
new checkpoints and biomarkers
-
0:28
immune checkpoint inhibitors: recent progress and potential biomarkers - 6i epigenetic signatures
-
28:05
identification of novel protein biomarkers in the era of precision medicine oncology
-
0:41
immune checkpoint inhibitors: recent progress and potential biomarkers - 6iii epigenetic signatures